Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.
Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, Woodworth KR, Nahabedian JF, Azziz-Baumgartner E, Gilboa SM, Meaney-Delman D, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. · 2020
Read Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. by Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, Woodworth KR, Nahabedian JF, Azziz-Baumgartner E, Gilboa SM, Meaney-Delman D, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7643892.txt.
Description
Zambrano and co-authors update data on women with COVID-19 by pregnancy status in the United States. Their report covers January 22 to October 3 in national case data. Pregnant women may face a higher risk of severe illness from the virus.
Reports covered 1,300,938 women aged fifteen to forty-four with confirmed infection. Pregnancy status was known for 461,825 of them. Among women with symptoms, 23,434 were reported to be pregnant at the time. After changes for age, race and health conditions, pregnant women faced more risk. Intensive care admission was ten point five versus three point nine per thousand cases. Use of a breathing machine and of ECMO support were also higher in pregnancy. Death was one point five versus one point two per thousand cases in the groups. The true risks for each woman stayed low, but the group gap was clear.
Catalog record
| CREATOR | Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, Woodworth KR, Nahabedian JF, Azziz-Baumgartner E, Gilboa SM, Meaney-Delman D, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |